Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Peterson DE et al. – rhITF oral spray formulation was safe and effective when used for the reduction of chemotherapy–associated OM in patients with colorectal cancer. Patients exhibited high compliance in dosing administration. Future clinical study is planned to develop this drug for use in OM management in patients with cancer.

Today in Colorectal Cancer/Polyps...keeping you current

Physical activity and male colorectal cancer survival
Archives of Internal Medicine, 12/14/09

Long-term outcomes after hepatic resection for colorectal metastases in young patients
Cancer, 12/14/09

Distinct features of colorectal cancer in children and adolescents
Cancer, 12/14/09

Today in Side Effects...keeping you current

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Journal of the National Cancer Institute, 12/14/09

Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/14/09

Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone
Clinical and Translational Oncology, 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address